Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.2395
Delayed Data
As of May 23
 +0.0043 / +1.83%
Today’s Change
0.21
Today|||52-Week Range
0.68
-33.19%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.24
Today’s open0.24
Day’s range0.24 - 0.25
Volume217,747
Average volume (3 months)299,652
Market cap$37.0M
Data as of 3:51pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)+2.22%
Earnings growth (this year)-86.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-91.76%
P/E ratioNM
Price/Sales32.00
Price/Book3.24

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...0.000.00%
FLKSFlex Pharma Inc-0.01-0.26%
CXRXConcordia Internatio...-0.01-2.65%
PTNPalatin Technologies...-0.03-2.65%
Data as of 8:00pm ET, 05/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.8M
Annual profit (last year)-$14.2M
Net profit margin-758.21%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
CFO, COO, Secretary &
Treasurer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts